Exagen (XGN)
(Delayed Data from NSDQ)
$2.40 USD
+0.36 (17.65%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $2.41 +0.01 (0.42%) 4:48 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Earnings News For XGN
-
Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates
-
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
-
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
-
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
-
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
-
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
-
Exagen Inc. Reports Strong Third Quarter 2023 Results
-
Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates
-
Exagen Inc. Reports Strong Second Quarter 2023 Results
-
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
-
Exagen Inc. Reports First Quarter 2023 Results
-
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
-
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
-
Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates
-
Exagen Inc. Reports Third Quarter 2022 Results
-
Exagen Inc. (XGN) Reports Q2 Loss, Lags Revenue Estimates
-
Exagen Inc. Reports Second Quarter 2022 Results
-
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
-
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
-
Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates
-
Earnings Preview: Exagen Inc. (XGN) Q3 Earnings Expected to Decline
-
Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates
-
Earnings Preview: Exagen Inc. (XGN) Q2 Earnings Expected to Decline
-
Earnings Preview: Exagen Inc. (XGN) Q1 Earnings Expected to Decline
-
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates